Ispire Technology Inc. (ISPR)
| Market Cap | 80.78M |
| Revenue (ttm) | 96.97M |
| Net Income (ttm) | -35.51M |
| Shares Out | 57.29M |
| EPS (ttm) | -0.62 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 36,582 |
| Open | 1.390 |
| Previous Close | 1.385 |
| Day's Range | 1.340 - 1.470 |
| 52-Week Range | 1.190 - 3.870 |
| Beta | 2.65 |
| Analysts | Strong Buy |
| Price Target | 7.50 (+431.92%) |
| Earnings Date | May 12, 2026 |
About ISPR
Ispire Technology Inc. researches, develops, designs, commercializes, sells, markets, and distributes e-cigarettes and cannabis vaping products worldwide under the Ispire and Aspire brands. The company was founded in 2010 and is headquartered in Los Angeles, California. Ispire Technology Inc. is a subsidiary of Pride Worldwide Investment Limited. [Read more]
Financial Performance
In fiscal year 2025, Ispire Technology's revenue was $127.49 million, a decrease of -16.07% compared to the previous year's $151.91 million. Losses were -$39.24 million, 165.7% more than in 2024.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for ISPR stock is "Strong Buy" and the 12-month stock price target is $7.5.
News
IKETech Wins "Privacy-Centric Age Assurance Solution of the Year," Recognized for Innovation at Global Industry Awards
Dual honors at GAAS Summit underscore growing regulatory and commercial validation for IKETech's point-of-use, privacy-first compliance platform LOS ANGELES, April 23, 2026 /PRNewswire/ -- IKETech LLC...
IKE Tech Engages FDA on Next-Generation Compliance Infrastructure for ENDS
Companies outline public health case for point-of-use enforcement technologies and call for regulatory framework recognizing compliance software as a tobacco product LOS ANGELES, April 9, 2026 /PRNews...
Ispire Highlights Economic Impact of New FDA Guidance on Flavored ENDS Unlocking a $50 Billion Market and Driving Significant Potential Asset Value
FDA establishes first-ever framework for flavored ENDS, recognizing device level age verification as a regulatory requirement FDA guidance unlocks an estimated $50 billion total addressable market, al...
Ispire Technology Inc. to Participate in the 38th Annual ROTH Conference
LOS ANGELES, March 11, 2026 /PRNewswire/ -- Ispire Technology Inc. ( NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today annou...
Ispire Technology Earnings Call Transcript: Q2 2026
Q2 2026 saw revenue decline due to a strategic pivot to high-value nicotine clients, but key metrics like net loss, operating expenses, and accounts receivable improved. Innovations in age-gating and G-Mesh technology, plus Malaysian facility expansion, position the company for future growth.
Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2026
Ongoing Focus on Collections Drives 19% Reduction in Net Accounts Receivable since June 30, 2025 Cash of $17.6 Million at December 31, 2025 LOS ANGELES, Feb. 6, 2026 /PRNewswire/ -- Ispire Techno...
Ispire-Backed IKE Tech Invited to Participate in FDA Roundtable on PMTA Submissions
Invitation-Only Forum Underscores FDA Recognition of IKE Tech as a Key Stakeholder and Highlights the Strategic Role of Age-Gating Technology in the Future of ENDS Regulation and Compliance LOS ANGELE...
Ispire Technology Inc. Schedules Fiscal Second Quarter 2026 Earnings Conference Call
LOS ANGELES, Feb. 3, 2026 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will hos...
Ispire Technology Unveils Next-Gen Cannabis Hardware Ecosystem at MJBizCon 2025
Company to Showcase Fully Reengineered Portfolio; Executive Team, Including Head of Sales John Monds, Available for On-Site Meetings LOS ANGELES , Nov. 26, 2025 /PRNewswire/ -- Ispire Technology Inc...
Ispire Technology and IKE Tech Applaud FDA Crackdown, Call for Tech-Driven Enforcement to Prevent Illicit Trade and Protect Youth
LOS ANGELES , Nov. 17, 2025 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), an innovator in vaping technology and precision dosing, and IKE Tech LLC ("IKE Tech"), ...
Ispire Technology Earnings Call Transcript: Q1 2026
Revenue and gross profit declined year-over-year due to a strategic exit from cannabis, but cost controls and a shift to higher-quality customers led to improved net loss and positive non-GAAP EBITDA. Expansion in nicotine technology and manufacturing capacity is expected to drive future growth.
Ispire Technology Inc. Reports Financial Results for Fiscal First Quarter 2026
Cost cutting measures instituted in Fiscal 2025 helped cut total operating expenses by approximately 39% to $7.8 Million year-over-year Net Accounts Receivable Reduced approximately 29% from $62.4 Mil...
Ispire Technology Inc. Schedules Fiscal First Quarter 2026 Earnings Conference Call
LOS ANGELES , Nov. 4, 2025 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will hos...
Ispire Technology Transcript: Planet MicroCap Showcase: TORONTO 2025
A global hardware innovator in nicotine and cannabis sectors, the company is advancing proprietary age-gating technology, expanding manufacturing in Malaysia to boost margins, and targeting major tobacco firms for licensing. Regulatory engagement and product innovation drive growth.
Ispire Technology Transcript: LD Micro Main Event XIX Investor Conference
Revenue reached $127 million with a global footprint and a focus on patented vaping technology. A blockchain-based age-gating solution is under fast-track FDA review, with potential for industry-wide licensing. Malaysian manufacturing expansion and GMESH innovation drive growth.
Ispire Technology Earnings Call Transcript: Q4 2025
Fiscal 2025 saw a strategic pivot from cannabis to nicotine, resulting in lower revenue but improved accounts receivable and significant cost savings. Investments in Malaysian manufacturing and age verification technology position the company for future growth, despite ongoing regulatory and market risks.
Ispire Technology Inc. Reports Financial Results for the Fiscal Year 2025
LOS ANGELES , Sept. 16, 2025 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today repor...
Ispire Technology Inc. Schedules Fiscal Fourth Quarter and Full Year 2025 Earnings Conference Call
LOS ANGELES , Sept. 12, 2025 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will h...
Ispire-Backed IKE Tech to Spotlight Breakthroughs in Vape Safety and Harm Reduction at World Vape Show Dubai
President of Ike Tech and SVP of International Nicotine at Ispire, John Patterson, to Join Global Leaders on Industry Innovation Panel LOS ANGELES , June 16, 2025 /PRNewswire/ -- Ispire Technology In...
Ispire-Backed IKE Tech to Present 7th Annual Next Generation Nicotine Delivery USA Conference
Conference Attendance Follows Groundbreaking FDA PMTA Filing for Blockchain-Powered Age-Gating System LOS ANGELES , June 3, 2025 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NA...
Ispire Technology Inc. Announces Approval of Interim License for Manufacturing of Nicotine Products in Malaysia
Interim License Approved in May, with Authority to Begin Manufacturing of Nicotine Products in Malaysia Immediately LOS ANGELES , May 22, 2025 /PRNewswire/ -- Ispire Technology Inc. ( NASDAQ: ISPR) ...
Ispire Technology Inc. Announces Appointment of Jay Yu as Chief Financial Officer
Jie "Jay" Yu has a strong track record of excellence in public company accounting, and has served in the role of Vice President of Finance for Ispire since June 2023 Ispire also further streamlines op...
This Cannabis Stock Sits Out The Rally Sparked By US-China Deal
The American vaping company with strong Chinese ties reported its revenue fell 12.7% in the three months to March, as it rushes to set up a new manufacturing facility in Malaysia
Ispire Technology Earnings Call Transcript: Q3 2025
Q3 2025 revenue declined 12.7% year-over-year to $26.2M, with gross margin down to 18.2%. Strategic milestones included a Malaysian manufacturing license, FDA filing for age verification tech, and new product launches. Tariff mitigation and supply chain shifts position the company for future growth.
Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2025
Accounts Receivable Decreased from $67.7M to $60.4M Improving Company Financial Position Post-Quarter End, IKE Tech Filed PMTA with the FDA for its Age-Gating Joint Venture Component with IKE Launched...